Bionomics Limited (BNOX) Stock Overview
Explore Bionomics Limited’s financial performance, market position, analyst ratings, and future outlook.
Bionomics Limited (BNOX)
Key Financials
Key Financials
Market Cap
5M
P/E Ratio
-0.00
EPS (TTM)
$-14.32
ROE
-0.08%
BNOX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Bionomics Limited (NASDAQ: BNOX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bionomics Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BNOX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Bionomics Limited's NASDAQ-traded stock include a P/E ratio of -0.00 and a market capitalization of 5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BNOX on the NASDAQ.